secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0000950170-23-052626
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kintara shareholders approve issuance of >20% of common stock to Lincoln Park Capital Fund
--------------------------------------------------------------------------------

- At special meeting Oct 9, 2023, Proposal 1 (issuance >20% of common stock to Lincoln Park Capital Fund) approved with 644,145 FOR, 39,208 AGAINST.
- Proposal 2 (adjournment if needed) also approved: 647,100 FOR, 36,634 AGAINST, 1,841 ABSTAIN.
- Approval permits Kintara to issue additional shares under the purchase agreement for capital raising.
- Dilution of existing shareholders likely given the issuance of more than 20% of outstanding common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000095017023052626/0000950170-23-052626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000095017023052626/ktra-20231009.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-052626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer